Ecto-ATPdiphosphohydrolase from normal and abnormal placenta

Kettlun, AM, Collados, L, García, L, Chayet, L, Mancilla, M, Acevedo, CG, Bravo, I, Aranda, E, Traverso-Cori, A., Valenzuela, MA.; Plesner, L, Kirley, TL, AF Knowles, AF.

Keywords: platelet aggregation, Adenylate Kinase, Immune Serum Extracellular Nucleotide, Placental Sample

Abstract

Vasoactive properties of adenosine and ATP on placenta has been described.1 Adenosine has been associated with vasodilation and ATP has a dual effect (vasodilation and vasoconstriction) depending on the receptors to which it binds. ADP is a powerful platelet stimulant, whereas ATP and adenosine inhibits ADP-induced platelet aggregation2. Mechanims of inactivation of circulating nucleotides, which imply the sequential degration of nucleoside di- and triphosphates to adenosine, are important in the control of their vascular actions. The scavenging of extracellular nucleotides is only possible in the dephosphorylated form3. We propose that ATP-diphosphohydrolase or apyrase (E. C. 3.6.1.5), characterized by its ATPase and ADPase activities, could be involved in the regulation of the extracellular nucleotide levels acting together with 5′-nueleotidase4. This enzyme has been found localized as an ectoenzyme in erythrocytes and platelets5,6, as well as in endothelial and smooth muscle cells7. Apyrase is different from the high affinity Ca2+-ATPase involved in the Ca2+ transport8 and its function has been associated to platelet aggregation inhibition. The placental tissue does not produce significant amounts of PGI2, a potent platelet antiaggregant and ADPase activity could be the most important part of the anti-platelet activity

Más información

Editorial: Springer
Fecha de publicación: 1997
Página de inicio: 49
Página final: 55
Idioma: Ingles
URL: https://link.springer.com/chapter/10.1007/978-1-4615-5955-9_7
DOI:

10.1007/978-1-4615-5955-9_7